We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

86 hedge funds and large institutions have $677M invested in Loxo Oncology, Inc in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

214% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 7

118% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 17

25% more capital invested

Capital invested by funds: $543M → $677M (+$133M)

19% more funds holding

Funds holding: 7286 (+14)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
86
Holders Change
+14
Holders Change %
+19.44%
% of All Funds
2.15%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
22
Increased
37
Reduced
17
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$3.08M +$491K +19,137 +25%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$2.96M -$223K -8,697 -9%
CS
28
Candriam SCA
Luxembourg
$2.57M +$2.05M +80,000 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$2.32M +$166K +6,465 +10%
USAA
30
United Services Automobile Association
Texas
$2.27M +$216K +8,420 +14%
PC
31
Polar Capital
United Kingdom
$2.25M +$1.8M +70,182 New
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$2.04M +$1.63M +63,640 New
Russell Investments Group
33
Russell Investments Group
United Kingdom
$1.81M +$1.4M +54,430 New
BIM
34
BlackRock Investment Management
Delaware
$1.77M +$88K +3,435 +7%
Teacher Retirement System of Texas
35
Teacher Retirement System of Texas
Texas
$1.74M +$495K +19,328 +55%
CLCM
36
Crawford Lake Capital Management
New Jersey
$1.69M +$1.35M +52,713 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.51M +$1.21M +47,176 New
SSA
38
Schonfeld Strategic Advisors
New York
$1.51M +$1.2M +46,900 New
Morgan Stanley
39
Morgan Stanley
New York
$1.42M +$984K +38,406 +646%
Charles Schwab
40
Charles Schwab
California
$1.39M +$59.2K +2,310 +6%
Goldman Sachs
41
Goldman Sachs
New York
$1.35M +$1.08M +42,133 New
CS
42
Credit Suisse
Switzerland
$1.35M +$1.08M +42,156 New
TCIM
43
TIAA CREF Investment Management
New York
$1.19M -$64K -2,495 -6%
Ameriprise
44
Ameriprise
Minnesota
$1.12M +$896K +34,940 New
SO
45
STRS Ohio
Ohio
$1.11M +$551K +21,477 +164%
Invesco
46
Invesco
Georgia
$908K -$124K -4,850 -15%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$882K +$704K +27,464 New
TA
48
Teachers Advisors
New York
$711K +$23.2K +905 +4%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$694K +$554K +21,623 New
AA
50
ALPS Advisors
Colorado
$669K -$174K -6,788 -25%

LOXO Hedge Fund Activity: Q4 2016 in Review

86 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q4 2016, worth a combined $677M — up 25% from $543M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LOXO positions and 7 closed out — a net gain of 15 holders — while 37 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $9.09M. The largest seller was NEA Management Company, exiting entirely with an estimated $33.8M sold.

  • 86 institutional investors held Loxo Oncology, Inc (LOXO) as of Q4 2016, up from 72 in Q3 2016.
  • Funds reported $677M of Loxo Oncology, Inc stock for Q4 2016, up 25% quarter-over-quarter.
  • 22 funds opened new Loxo Oncology, Inc positions in Q4 2016 and 7 closed out, a net change of +15 holders.
  • The largest Loxo Oncology, Inc buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $9.09M added.
  • The largest Loxo Oncology, Inc seller in Q4 2016 was NEA Management Company, an estimated $33.8M sold.

Based on aggregated 13F filings for Q4 2016.